Page last updated: 2024-11-03

pyrimethamine and Porphyria Cutanea Tarda

pyrimethamine has been researched along with Porphyria Cutanea Tarda in 1 studies

Maloprim: contains above 2 cpds

Porphyria Cutanea Tarda: An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belda Mira, A1
Rovira Daudí, E1
Díaz Sánchez, F1
Michavila Gómez, J1

Other Studies

1 other study available for pyrimethamine and Porphyria Cutanea Tarda

ArticleYear
[Porphyria cutanea tarda and human immunodeficiency virus infection. Apropos of 2 further cases].
    Revista clinica espanola, 1994, Volume: 194, Issue:7

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Drug Therapy, Combination; HIV Infectio

1994